CTFA Standards - SANS 98:2012 – Ingredient Labelling of Cosmetic Products

SANS 98:2012 Edition 1.1 8 5.3 Ingredients that require "Warning" or "Caution" statements There are several ingredients listed in annexes III, VI and VII of chapter 4, section 11 of the CTFA cosmetic compendium. These ingredients shall be labelled with "Warning" or "Caution" statements as given in column 5 ("Other limitations and requirements") and column 6 ("Conditions of use and warnings to be printed on the label") of the above-mentioned annexes. They shall also be listed as part of the ingredients, using the INCI nomenclature. 5.4 Ingredients with restricted use 5.4.1 Ingredients with restricted use (see 3.1.7) shall be listed in the INCI nomenclature, as part of the ingredient list, and separately as specified in column 6 of annexes III, VI and VII of chapter 4, section 11 of the CTFA cosmetic compendium ("Conditions of use and warnings to be printed on the label"). 5.4.2 Imported products classified as cosmetics in South Africa, but known as "OTC drugs for human use" in the USA, shall be labelled with the active ingredient and the established drug name (as in the US Pharmacopoeia) and the quantity of the ingredient on both the primary packaging (see 3.1.11) and secondary packaging (see 3.1.12). 6 Nomenclature used for ingredient labelling 6.1 General 6.1.1 The raw material supplier should take the necessary steps to ensure that an INCI name is applied for, and when allocated, the INCI name shall without unnecessary delay be used in the ingredient declaration. 6.1.2 There are several differences between the USA and EU interpretations of the INCI nomenclature. Users should review the applicable national laws and regulations of the relevant region to ensure that the INCI nomenclature used for labelling is appropriate for their intended markets. The following list indicates where differences in interpretation of the INCI nomenclature between the USA and the EU are most frequently encountered: a) colourants; b) botanicals; c) denatured alcohol; d) USA OTC drug ingredients; e) trivial names; and f) fragrance or parfum and flavor or aroma (see 6.2.1). 6.1.3 If the harmonized labelling system is used, the EU INCI nomenclature and the trivial name for each ingredient should follow each other (see column 2 of table B.1). © SABS © SABS. This non-printable standard is exclusively for members of the Cosmetic, Tolietry and Fragrance Association of South Africa (ctfa) granted access online through its password-protected and member-specific portal in accordance with publishing and copyright exploitation agreement no. 014/009/20-049. The agreement will expire after one year unless renewed. © SABS. This non-printable standard is exclusively for members of the Cosmetic, Tolietry and Fragrance association of South Africa (ctfa).